MENU
PLX
AS OF
Feb 3 closing price
Price
$2.73
Change
+$0.17 (+6.64%)
Capitalization
219.55M
36 days until earnings call
Intraday BUY SELL Signals
+Compare
PLX
Stock ticker: ASE
AS OF
Feb 3 closing price
Price
$2.73
Change
+$0.17 (+6.64%)
Capitalization
219.55M

PLX Protalix BioTherapeutics Forecast, Technical & Fundamental Analysis

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

PLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PLX with price predictions
Feb 03, 2026

Momentum Indicator for PLX turns positive, indicating new upward trend

PLX saw its Momentum Indicator move above the 0 level on January 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

PLX moved above its 50-day moving average on January 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PLX crossed bullishly above the 50-day moving average on January 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for PLX moved above the 200-day moving average on February 03, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PLX advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where PLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLX broke above its upper Bollinger Band on January 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.149) is normal, around the industry mean (27.519). P/E Ratio (34.125) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (3.741) is also within normal values, averaging (331.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PLX is expected to report earnings to rise 16.67% to 3 cents per share on March 12

Protalix BioTherapeutics PLX Stock Earnings Reports
Q4'25
Est.
$0.04
Q3'25
Missed
by $0.04
Q2'25
Missed
by $0.15
Q1'25
Missed
by $0.08
Q4'24
Est.
$0.10
The last earnings report on November 13 showed earnings per share of 2 cents, missing the estimate of 7 cents. With 2.53M shares outstanding, the current market capitalization sits at 219.55M.
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCHVY19.502.00
+11.43%
MGM China Holdings, Ltd.
KTGDF0.550.04
+7.39%
K2 Gold Corp
SAABY38.270.50
+1.32%
Saab AB
BBOP1.00N/A
N/A
BeBop Channel Corporation
SILXF4.67-0.03
-0.64%
Silex Systems Ltd.

PLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+11.11%
IOVA - PLX
44%
Loosely correlated
+2.35%
ADMA - PLX
33%
Loosely correlated
+1.16%
STOK - PLX
31%
Poorly correlated
+1.42%
ZNTL - PLX
31%
Poorly correlated
+3.29%
CPRX - PLX
31%
Poorly correlated
+2.88%
More